CN114796359A - Implementation method for applying agilawood to human respiratory tract absorption - Google Patents

Implementation method for applying agilawood to human respiratory tract absorption Download PDF

Info

Publication number
CN114796359A
CN114796359A CN202210355737.XA CN202210355737A CN114796359A CN 114796359 A CN114796359 A CN 114796359A CN 202210355737 A CN202210355737 A CN 202210355737A CN 114796359 A CN114796359 A CN 114796359A
Authority
CN
China
Prior art keywords
agilawood
respiratory tract
mixture
applying
human respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210355737.XA
Other languages
Chinese (zh)
Inventor
俞玉平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202210355737.XA priority Critical patent/CN114796359A/en
Publication of CN114796359A publication Critical patent/CN114796359A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/83Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835Aquilaria
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10Devices using liquid inhalable precursors
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40Constructional details, e.g. connection of cartridges and battery parts
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/46Shape or structure of electric heating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0016Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Otolaryngology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a method for realizing application of agilawood to human respiratory tract absorption, which comprises the steps of mixing agilawood extracting solution, glycerol and propylene glycol to form an agilawood basic mixture; adding a food cooling agent to the agilawood base mixture to form an agilawood primary taste mixture; adding flavoring food essence based on the original flavor mixture of lignum Aquilariae Resinatum to obtain flavored lignum Aquilariae Resinatum mixed solution; stirring the flavor type agilawood mixed solution to form an atomized mixed solution, filtering and canning; and selecting an atomization device with a heating plate to heat the atomized mixed liquid into a mist shape. According to the invention, the agilawood formula which can meet the application requirements of most agilawood using groups is combined with the atomizing device to promote the absorption of agilawood components carried by agilawood atomizing gas to respiratory mucosa and the exertion of drug permeability, so that the agilawood atomizing gas is not only beneficial to relieving mental deficiency and arrhythmia, but also has the effects of condensing qi, soothing the nerves and reducing pressure, and is also beneficial to exerting a basic antibacterial effect.

Description

Implementation method for applying agilawood to human respiratory tract absorption
Technical Field
The invention relates to an agilawood application technology, in particular to a realization method for applying agilawood to human respiratory tract absorption.
Background
The Chinese nation has a long history of incense culture, and the incense medicine belongs to plants, and is also an aromatic medicine in the traditional Chinese medicine, such as agilawood, sandalwood, storax, frankincense, clove and the like. The properties of herbs are defined in detail and authoritative in the classic of traditional Chinese medicine such as Ben Cao gang mu and Shen nong Ben Cao Jing, and the common point of them is that they have the actions of eliminating pathogenic factors and strengthening body resistance, relieving dysmenorrhea and curing diseases and preserving health, for example, in Shen nong Ben Cao Jing Shu, it is said that all the evil qi must enter from mouth and nose. The mouth and nose are orifices of yangming meridians, and the aversion to qi is easy to be manifested by deficiency of yangming meridians. When the fragrant and yang-clearing qi is obtained, the aversion to qi will go away and the spleen and stomach will calm . People can form various formulas according to the comprehensive medicinal properties of the fragrant medicines and according to monarch, minister, assistant and guide, and prepare fragrant products with various formulations and shapes so as to achieve the effects of health preserving and health care, disease preventing and treating, sexual intercourse controlling, environment building and beautifying. As can be seen, the effect of taste on the human body has been studied for a long time.
In recent years, research and analysis prove that after odor molecules are absorbed by respiratory mucosa, the generation of human immunoglobulin can be promoted, and the resistance of a human body is improved; the odorant molecules can stimulate olfactory cells of a human body, inhibit activities through excitation of cerebral cortex, regulate metabolism of the whole body, balance vegetative nerve functions, and achieve relative stability of physiological and psychological functions, which proves the important role of the aroma on human health preservation from the perspective of modern science. For example, the Chinese eaglewood according to the technical scheme of the invention has the true value of Chinese eaglewood in removing floating, eliminating irritability, calming and improving will; in the division of the traditional Chinese medicine into medicinal materials, the Chinese eaglewood can enter the channels of heart, kidney, stomach, spleen and the like, is named as the superior Chinese herbal medicine, has a remarkable effect on stroke and coma caused by cardiovascular and cerebrovascular diseases, has very wide other uses, has the medicines of 'Chinese eaglewood qi-transforming pill', 'Chinese eaglewood qi-moving pill', 'Chinese eaglewood qi-dispersing pill', 'Chinese eaglewood qi-regulating pill', 'Chinese eaglewood qi-dispersing pill' and the like only by taking the Chinese eaglewood as the name, and has a countless number of prescriptions for the Chinese eaglewood into the medicine.
However, the fragrance can be simply smelled by the nose, but through the reaction of the brain, each organ of the body gathers and feels the fragrance of the agilawood, so that the fragrance has a good curative effect, and the reason why the aromatherapy can be handed from the old to the present is also the reason. The induction of aroma by organs or cells of the human body is real, and different tastes are targeted to different organs.
The technical personnel can know through the analysis of the application effect of the traditional Chinese eaglewood, and the Chinese eaglewood atomizing gas carries the Chinese eaglewood components to exert the medicine properties of respiratory mucosa and permeability, so that the Chinese eaglewood atomizing gas is quite suitable for human bodies, Chinese people have wide recognition of the smell of the Chinese eaglewood, and the Chinese eaglewood atomizing gas is used as a guiding drug in a Chinese medicine formula, so that the Chinese eaglewood atomizing gas can be used as an atmosphere rendering of the environment and has the functions of refreshing and restoring consciousness.
Researchers in the technical scheme of the invention carry out experiments and analyses on the medicinal composition and efficacy of the traditional Chinese medicine formula of the same type of agilawood while implementing the method, and find that the effect of agilawood atomizing gas carrying agilawood components on respiratory mucosa and drug permeability is not obvious in the prior art, agilawood must be ignited in a specific environment or decocted in a traditional Chinese medicine crock when the agilawood is used, and obviously, the limitation of agilawood application is exposed suddenly; meanwhile, the medicinal effect of the agilawood cannot be improved due to the complex raw material preparation or unreasonable raw material ratio of the traditional agilawood mixture, the process is not favorable for gradual progress, and the application effect of agilawood atomization is further improved by utilizing devices such as an electronic cigarette and the like at present.
In summary, the invention provides a method for applying agilawood to human respiratory tract absorption based on the existing agilawood atomization technology and by combining clinical application and practical effects, the traditional Chinese medicine formula is completely gradually optimized step by step, after practical verification is carried out on the intermediate scheme adopted by each research and development stage by research and development personnel, different intermediate schemes are carried out, and finally the optimal optimized technical scheme is obtained, so that the agilawood atomization method is suitable for agilawood application groups and meets the use requirements of the agilawood application groups, and the agilawood atomization method is not only beneficial to relieving mental deficiency and arrhythmia, plays the effects of condensing qi, soothing the nerves and reducing pressure, but also is beneficial to exerting the basic antibacterial effect. Therefore, the technical scheme provided by the invention can relieve, partially solve or solve the problems in the prior art.
Disclosure of Invention
Aiming at the defects, the invention provides a method for realizing the application of agilawood to the respiratory tract absorption of a human body, which adopts an agilawood material formula which can meet the requirements of most agilawood application groups and can combine the existing electronic heating ceramic chip to play an atomizing function, thereby being beneficial to the exertion of the permeability of agilawood atomizing gas carrying agilawood when the agilawood atomizing gas is absorbed by respiratory tract mucosa, being beneficial to relieving the mental deficiency and arrhythmia, playing the effects of condensing qi, soothing the nerves and reducing pressure and being beneficial to the exertion of a basic antibacterial effect.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method for applying agilawood to human respiratory tract absorption adopts an atomizing device which is suitable for practical application requirements, and comprises the following steps:
taking 1-5 parts by weight of agilawood extracting solution, and taking glycerol and propylene glycol, wherein the glycerol and the propylene glycol are mixed according to the weight ratio of 1: 1. 6: 4. 7: 3 or 8: 2, mixing the three raw materials to form an agilawood basic mixture;
II, adding WS-23 type food cooling agent which is 2 to 4 weight percent of the agilawood basic mixture to form an agilawood original taste mixture;
III, properly adding a flavor food essence which is 10 to 15 weight percent of the agilawood basic mixture on the basis of the agilawood original flavor mixture to prepare a flavor type agilawood mixed solution;
IV, stirring the flavor type agilawood mixed solution, directly rotating at 200-300 revolutions per minute for 25-30 minutes if the external temperature is 20-30 ℃, forming an atomized mixed solution after stirring, filtering and canning;
and V, selecting an atomizing device with a heating sheet, heating the atomized mixed liquid into a mist state, and enabling the agilawood atomized gas carrying the agilawood component to be absorbed and permeated by respiratory tract mucosa.
Aiming at the steps, technicians can also optimize according to different application requirements to form different technical schemes, including:
the atomization device comprises an electronic cigarette with an electronic heating ceramic chip;
for the agilawood original flavor mixture, the mixture can be directly stirred to form an atomized mixed solution;
for the basic mixture of lignum Aquilariae Resinatum, flavoring food essence can be directly added to make into taste type lignum Aquilariae Resinatum mixed solution;
wherein the food cooling agent can be menthone.
Wherein the flavor food essence comprises apple, banana, tea or animal and plant flavor essence.
When the above technical scheme is further implemented, the adjustment can be carried out according to different conditions, and the method comprises the following steps:
when stirring, if the external temperature is lower than the normal temperature, heating to more than 20 ℃ is needed to ensure the good mixing and dissolving state of the base liquid prepared by matching the glycerol and the propylene glycol;
for glycerin, the amount of atomized smoke is increased by increasing its weight.
The atomization device heats the tobacco tar inside to dialyze by the micropore, and the gas carrying the medicine components is evaporated.
According to the method for realizing the absorption and application of the agilawood in the respiratory tract of a human body, the agilawood atomization gas is combined with the atomization device to promote the absorption of agilawood components carried by the agilawood atomization gas on the respiratory tract mucosa and the exertion of the permeability drug property by adopting a formula which can meet the application requirements of most agilawood use groups, so that the method is not only beneficial to relieving the mental deficiency and arrhythmia, but also has the effects of condensing qi, soothing the nerves and reducing pressure, and is also beneficial to exerting the basic antibacterial effect.
Drawings
The invention is explained in further detail below with reference to the drawing.
Fig. 1 is a schematic flow chart of a method for implementing the application of agilawood to human respiratory tract absorption, which is implemented by the invention.
Detailed Description
The technical scheme of the invention is to implement a method for realizing the application of agilawood to human respiratory tract absorption, and aims to solve the application limitation that agilawood must be ignited in a specific environment or suddenly leaked by using traditional Chinese medicine crock to boil when agilawood is used for health care in the past, and the medicinal effect of agilawood cannot be improved due to the complex preparation of raw materials of an agilawood mixture or unreasonable proportion of the raw materials in the past.
The technical scheme of the invention is that different medicines are reasonably combined to form a traditional Chinese medicine formula with a health-care effect, and then a proper atomization way is selected, so that the corresponding technical problem is finally relieved or solved. In addition, because the dosage of each traditional Chinese medicine is in a certain range when the traditional Chinese medicines are adopted in proportion, different schemes can be selected according to the preparation requirements, the effects exerted by different raw material proportions cannot be considered to be completely the same in a one-sideview manner, and the technical scheme of the invention is mainly characterized in that the formula formed by utilizing the agilawood extract, the propylene glycol, the glycerol and the taste enhancer is adopted, so that the selection of medicine preparation equipment, an atomizing device and the like is not improved compared with the conventional technical means, and the increase and decrease of the dosage can be carried out according to the requirements. Obviously, the technical solution of the present invention does not involve selecting what kind of equipment to stir, what kind of atomization device to match, and other corresponding technical and conventional means, and those skilled in the art know that it is necessary to additionally refer to some conventional technical means as long as the technical means of the technical solution of the present invention can be implemented, and those skilled in the art can combine with actual design requirements; of course, it is not limited to the selection of the apparatus, the model of the device, and the like. Therefore, the technical scheme of the present invention is a method for implementing the agilawood for respiratory tract absorption, which can be referred and implemented by a person skilled in the art by combining with conventional technical means, and the person skilled in the art can actually obtain a series of advantages according to different application conditions and requirements, and the advantages will be gradually reflected in the following analysis.
The invention discloses a method for realizing application of agilawood to human respiratory tract absorption, which is implemented by the following steps of firstly mixing agilawood extracting solution with glycerol, propylene glycol, a palatability material and a cooling agent according to a certain proportion to prepare an atomized mixed solution, wherein the materials can be selected according to parts by weight and can be specifically expressed by a numerical range, and certainly, the preparation technology needs to be optimized according to specific formula dosage parameters.
After the materials are proportioned, the atomized mixed liquid can be heated into fog for sucking through the mature prior art at present, for example, an electronic cigarette with an electronic heating ceramic chip, so that the inconvenience caused by burning agilawood to emit smell in a specific environment (such as a room) or decocting traditional Chinese medicines to obtain the traditional Chinese medicines can be overcome, and the aim of using agilawood to preserve health through electronic atomization at any time in a portable manner is fulfilled.
The implementation method of applying the agilawood to the respiratory tract absorption of the human body, which is to be implemented by the invention, has a direct or indirect effect on the agilawood, such as prolonging the sleeping time of the human body and improving the sleeping in the aspect of sleeping; for another example, in the aspect of pressure reduction, as the pressure felt by most people is multiplied due to the accelerated pace of life, the invention is beneficial to relieving and treating the heart-spirit deficiency, and achieves the effects of condensing qi, soothing the nerves and releasing the pressure; for another example, the agilawood has strong antibacterial effect, and particularly has better inhibition effect on tubercle bacillus; in addition, the health of heart and cerebral vessels is favorably regulated, and the agilawood has the effect of resisting arrhythmia after entering a body.
Meanwhile, in order to prove that the implementation method of applying the agilawood to the respiratory tract absorption of the human body, which is to be implemented by the invention, can meet different requirements of agilawood using groups, research and development personnel also carry out objective group investigation at the beginning of the design of the technical scheme, and real and effective survey data are obtained. As shown in the following tables, the groups are respectively expressed as taste types, groups expressed as odor types, groups expressed as auxiliary improvement effects and groups expressed as beneficial to environment and body, and research results show that in the application groups, not all people want to obtain the same type of effect, so that the traditional agilawood preparation and application method can not meet the requirements of different groups on the basis of ensuring the application effect of agilawood, therefore, the invention actually has the group capable of meeting various different requirements in the application groups, and the invention aims at reasonable preparation of agilawood formula (comprising a proper amount of proportioning of agilawood extract, propylene glycol, glycerol, cooling agent, flavor essence and the like), improvement of processing process (comprising stirring mode, processing condition and the like) and optimization of agilawood application process (comprising atomization means), obviously, the advantages of the technical scheme of the invention can be embodied in various aspects.
Figure BDA0003582435390000061
As shown in fig. 1, in the specific implementation of the method for implementing agilawood absorption in the respiratory tract of a human body according to the present invention, for the preparation of raw materials, agilawood extract (i.e., agilawood essential oil) is mainly used, and is coordinated with base oil propylene glycol, glycerol and related taste type food essences (e.g., fruit taste, flower taste, etc.) for auxiliary blending, and finally, a cooling agent (e.g., menthone) is added, and the specific method is as follows:
firstly, taking 1-5 parts by weight of agilawood extract, and then taking proper parts by weight of glycerol (glycerol) and propylene glycol, wherein the ratio of glycerol to propylene glycol is 1: 1, mixing the three raw materials to form an agilawood basic mixture (the weighed tools are sterilized by medical alcohol and then operated to ensure sterility); to the weight ratio of glycerine and propylene glycol, not to be in the fixed proportion, the purpose is the cooperation is decided with the cigarette rod of using and the dense of atomizing smog, and the higher the glycerine ratio then smog volume is big more and the precision is higher, therefore, the weight ratio can also be 6: 4. 7: 3. 8: 2 or other suitable ratios as actually verified;
then, adding WS-23 type food cooling agent, preferably menthone, in an amount of 2% -4% by weight to the above-formed agilawood base mixture to form an agilawood primary taste mixture; for the addition of the food cooling agent, if the weight of the agilawood basic mixture is 100 parts, 3-5 parts of the agilawood basic mixture can also be added;
meanwhile, on the basis of the agilawood original taste mixture, according to the requirements of customers and market demands, a taste food essence which is 10-15% of the agilawood basic mixture, such as apple, banana, tea, animal and plant essence, can be properly prepared to prepare a taste type agilawood mixed solution;
and finally, stirring the flavor type agilawood mixed solution, directly changing the external temperature to 200-300/min for 25-30 min at the temperature of 20-30 ℃, heating to the temperature of more than 20 ℃ if the external temperature is lower than the normal temperature to ensure the base solution with the ratio of the glycerol to the propylene glycol to be in a good mixed dissolving state, forming an atomized mixed solution after stirring, filtering and canning.
Furthermore, when how to specifically apply the nebulizable mixed liquid to human respiratory tract absorption is selected, the resistance of the electronic heating ceramic chip can generate heat through the currently mature technical means of the nebulizing device such as the electronic cigarette with the electronic heating ceramic chip, the tobacco oil inside the electronic heating ceramic chip is dialyzed by the ceramic micropores, the evaporated gas which is relatively thick and carries the medicine components enters the oral cavity along the suction hole, and the high temperature is generated when the resistance generates heat, so that the nebulization occurs.
According to various previous researches, agilawood atomizing gas carrying agilawood components is quite suitable for human bodies through the exertion of respiratory tract mucosa and osmotic drug property, is convenient to carry about, and can be sucked at any time through an electronic atomizer to obtain a medicament, so that time and labor are saved, and the health maintenance is facilitated; the atomizing inhalation overcomes the limitation that the agilawood must be ignited in a specific environment (in a room) to generate pleasant smell in the past, and also overcomes the inconvenience of obtaining the medicament due to the decoction of traditional Chinese medicines in a crock.
In the description herein, the appearances of the phrases "embodiment one," "this embodiment," "specific implementation," and the like in this specification are not necessarily all referring to the same embodiment or example, but rather to the same embodiment or example. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example; furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
In the description of the present specification, the terms "preparing", "proportioning", "having", and the like are to be understood in a broad sense, and the specific meanings of the above terms in the present invention can be understood by those skilled in the art according to specific situations as in the present example.
The foregoing description of the embodiments is provided to enable any person skilled in the art to make and use the embodiments, and it is to be understood that various modifications may be readily apparent to those skilled in the art, and that the generic principles defined herein may be applied to other embodiments without the use of the inventive faculty. Therefore, the present disclosure is not limited to the above embodiments, and modifications to the following cases should be included within the scope of the present disclosure: based on the technical scheme of the invention, for example, the technical scheme is implemented by utilizing agilawood extract, propylene glycol and glycerol and combining the existing electronic heating ceramic chip, and the technical effect generated by the novel technical scheme is not beyond the technical effect of the invention and is not beyond the technical effect of the invention; equivalent replacement of part of the characteristics of the technical scheme of the invention by adopting the known technology produces the same technical effect as the invention, for example, replacement of different selected atomization devices; expanding on the basis of the technical scheme of the invention, wherein the substantial content of the expanded technical scheme does not exceed the technical scheme of the invention; and fourthly, the technical means obtained by utilizing the equivalent transformation carried out by the text record content of the invention is applied to other related technical fields.

Claims (10)

1. The method for realizing the application of the agilawood to the respiratory tract absorption of the human body adopts an atomizing device which is suitable for the actual application requirement, and is characterized by comprising the following steps of:
taking 1-5 parts by weight of agilawood extracting solution, and taking glycerol and propylene glycol, wherein the glycerol and the propylene glycol are mixed according to the weight ratio of 1: 1. 6: 4. 7: 3 or 8: 2, mixing the three raw materials to form an agilawood basic mixture;
II, adding WS-23 type food cooling agents which are 2 to 4 weight percent of the agilawood basic mixture to form an agilawood original taste mixture;
III, properly adding a taste food essence which is 10 to 15 weight percent of the agilawood basic mixture on the basis of the agilawood original taste mixture to prepare a taste type agilawood mixed solution;
IV, stirring the flavor type agilawood mixed solution, directly rotating at 200-300 revolutions per minute for 25-30 minutes if the external temperature is 20-30 ℃, forming an atomized mixed solution after stirring is finished, filtering and canning;
and V, selecting an atomizing device with a heating sheet, heating the atomized mixed liquid into a mist state, and enabling the agilawood atomized gas carrying the agilawood component to be absorbed and permeated by respiratory tract mucosa.
2. The implementation method of applying agilawood to human respiratory tract absorption according to claim 1, characterized in that: the atomization device comprises an electronic cigarette with an electronic heating ceramic chip.
3. The implementation method of applying agilawood to human respiratory tract absorption according to claim 1, characterized in that: the agilawood original flavor mixture can be directly stirred to form an atomized mixed solution.
4. The implementation method of applying agilawood to human respiratory tract absorption according to claim 1, characterized in that: the basic mixture can be directly added with flavoring food essence to obtain flavored mixed solution of lignum Aquilariae Resinatum.
5. The implementation method of applying agilawood to human respiratory tract absorption according to any one of claims 1-4, wherein: the food cooling agent is menthone.
6. The implementation method of applying agilawood to human respiratory tract absorption according to claim 1, characterized in that: the flavor food essence comprises apple, banana, tea or animal and plant flavor essence.
7. The implementation method of applying agilawood to human respiratory tract absorption according to claim 1, characterized in that: when stirring, if the external temperature is lower than the normal temperature, the temperature is required to be heated to more than 20 ℃ so as to ensure the base liquid with the ratio of glycerol to propylene glycol to be in a good miscible state.
8. The implementation method of applying agilawood to human respiratory tract absorption according to claim 1, characterized in that: for glycerin, the amount of atomized smoke is increased by increasing its weight.
9. The implementation method of applying agilawood to human respiratory tract absorption according to claim 1, characterized in that: the atomization device heats the tobacco tar inside the atomization device to be dialyzed by the micropores, and gas carrying the medicine components is evaporated.
10. The method for realizing the application of agilawood to human respiratory tract absorption according to claim 1, which is characterized in that: if the weight of the agilawood base mixture is 100 parts, 3-5 parts of the agilawood base mixture can be added.
CN202210355737.XA 2022-04-06 2022-04-06 Implementation method for applying agilawood to human respiratory tract absorption Pending CN114796359A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210355737.XA CN114796359A (en) 2022-04-06 2022-04-06 Implementation method for applying agilawood to human respiratory tract absorption

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210355737.XA CN114796359A (en) 2022-04-06 2022-04-06 Implementation method for applying agilawood to human respiratory tract absorption

Publications (1)

Publication Number Publication Date
CN114796359A true CN114796359A (en) 2022-07-29

Family

ID=82533117

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210355737.XA Pending CN114796359A (en) 2022-04-06 2022-04-06 Implementation method for applying agilawood to human respiratory tract absorption

Country Status (1)

Country Link
CN (1) CN114796359A (en)

Similar Documents

Publication Publication Date Title
CN100506241C (en) Smoking-stopping health inhalant and its making process
CN111110898A (en) Herbal original dew atomized liquid with essence
CN100569225C (en) Appetite suppressant and fat-reducing conditioner
KR20120131970A (en) Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same
CN106912982A (en) A kind of electronic cigarette tobacco tar and preparation method thereof
CN110403869A (en) A kind of plant is releived composite essential oil and preparation method thereof
CN110367582A (en) Electronic cigarette liquid
CN112075459A (en) Antiviral and antibacterial respiratory tract compound essential oil and preparation method thereof
CN107362323A (en) A kind of preparation for improving sleep and preparation method thereof
CN113662234B (en) Antibacterial atomized liquid and preparation method thereof
CN111150822A (en) Multifunctional herbal essence atomized liquid
Stiles The essential oils complete reference guide: Over 250 recipes for natural wholesome aromatherapy
CN105713725A (en) Space capsule and plant compound essential oil for lowering blood pressure and application method thereof
CN107412343A (en) Refresh oneself spraying and preparation method thereof
CN114796359A (en) Implementation method for applying agilawood to human respiratory tract absorption
CN101773291A (en) Mixed cigarette
CN111437368A (en) Herbal original dew atomized liquid
CN106511551A (en) Eupatorium fortunei compound essential oil for improving early morning awakening
CN109758520A (en) A kind of compound essential oil with anti-insomnia effect
CN104740444A (en) Compound essential oil spray with refreshing function
CN111642786B (en) Chinese herbal medicine tea cigarette with epidemic prevention and health care effects and application thereof
CN113332345A (en) Traditional Chinese medicine composition for soothing nerves and beautifying and preparation method thereof
CN109432318B (en) Compound essential oil, application thereof and compound essential oil product
CN114085711A (en) Plant essence for electronic atomized liquid and preparation method thereof
CN112704697A (en) Atomized liquid for resisting epidemic and maintaining respiratory tract health and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination